CureVac Announces Changes of CDO – Myriam Mendila to Succeed Klaus Edvardsen
Myriam Mendila appointed as Chief Development Officer starting from February 1, 2023Klaus Edvardsen returning to Denmark after holding numerous leadership...
Staff
Novamind Shareholders Approve Proposed Acquisition by Numinus
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Cloud DX Signs Fourth Paramedicine Provider; contracts signed have increased 142% YoY
Fourth Emergency Medicine Services (EMS) contract in 2022 as more EMS choose the Cloud DX Virtual Care PlatformKITCHENER, ON /...
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today...
ESO Adds Industry Luminary Dr. Eric Beck to Executive Team
Beck joins company as president, brings more than 20 years of experience AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading data and software...
Lazurite™ Named One of the Industry’s Hottest Companies by World’s Largest MedTech Accelerator
CLEVELAND--(BUSINESS WIRE)--#MedTechInnovator--MedTech Innovator, the world’s largest accelerator of medical technology companies, yesterday named Lazurite as one of the MedTech industry’s...
MyWoundDoctor Appoints Donato Tramuto to Board of Directors
NASHVILLE, Tenn.--(BUSINESS WIRE)--MyWoundDoctor, a leader in providing expert wound care management, announced the appointment of Donato Tramuto to its Board...
Rushnet, Inc Pursues Spinoff of HeliosDX, Dividend
ALPHARETTA, GA / ACCESSWIRE / June 8, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce the...
Highmark Interactive Inc. Demonstrates Traction in the US Market Deploying its EQ Remote Physiologic Monitoring Platform with Large, Multi-Site Orthopedic Organization
Highmark announces immediate deployment of its remote physiologic monitoring software across a large 10,000 patient plus multi-clinic orthopedic organization in...
Altamira Therapeutics Reports 89.5% and 98.9% Reduction in Viral Load Against Human Rhinovirus With its Bentrio Nasal Spray
Testing further confirms Bentrio's broad protection against various types of airborne virusesDemonstrates significant reductions in viral load for preventive and...
Halberd Corp. & Mississippi State University Discuss Animal Testing as Prelude to FDA Certification
JACKSON CENTER, PA / ACCESSWIRE / June 8, 2022 / Halberd Corporation (OTC PINK:HALB) and Mississippi State University (MSU) executed...
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
New Delivery of Dosell to Apoteket AB
STOCKHOLM, SE / ACCESSWIRE / June 8, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that a large amount...
Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron
Data Show Significantly Higher Geometric Mean Titer Ratios, Meeting Prespecified Endpoints for Superiority Against Omicron VariantmRNA-1273.214 Exhibited an 8-Fold Boost...
Zomedica to Present at JMP Securities Life Sciences Conference
ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
SPO Global Inc. Discusses Company’s Medical Devices
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today...
Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers
Strategic partnership will focus on improving regulatory outcomes in therapist training and safe supply of psilocybinVANCOUVER, British Columbia, June 08,...
Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms
Double-Blind, Peer-Reviewed Study Presented at 2022 ACSM Annual Meeting Photo 1 UBN RELIEF™ is clinically proven to provide some relief...
CorMedix to Participate at the JMP Securities Life Sciences Conference
BERKELEY HEIGHTS, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
SCYNEXIS Announces Submission of Supplemental New Drug Application of BREXAFEMME® (ibrexafungerp tablets) to the U.S. Food and Drug Administration for an Expanded Indication for the Prevention of Recurrent Vaginal Yeast Infections
Regulatory submission for the label extension is supported by positive data from the pivotal Phase 3 CANDLE study in which...